Network Meta-analysis of Progression-Free Survival and Overall Survival in First-Line Treatment of BRAF Mutation-Positive Metastatic Melanoma

被引：0
|
作者：
Jordan Amdahl
Lei Chen
Thomas E. Delea
机构：
[1] Policy Analysis Inc. (PAI),
[2] Novartis Pharmaceuticals,undefined
来源：
Oncology and Therapy | 2016年 / 4卷 / 2期
关键词：
Clinical trials; Melanoma; Network meta-analysis;
D O I：
10.1007/s40487-016-0030-2
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：239 / 256
页数：17
相关论文
共 50 条
  • [41] Retrospective analysis of independent predictors of progression-free survival in patients with EGFR mutation-positive advanced non-small cell lung cancer receiving first-line osimertinib
    Teranishi, Shuhei
    Sugimoto, Chihiro
    Nagaoka, Satoshi
    Nagayama, Hirokazu
    Segawa, Wataru
    Miyasaka, Atsushi
    Hiro, Shuntaro
    Kajita, Yukihito
    Maeda, Chihiro
    Kobayashi, Nobuaki
    Yamamoto, Masaki
    Kudo, Makoto
    Kaneko, Takeshi
    THORACIC CANCER, 2022, 13 (19) : 2741 - 2750
  • [42] Hepatic Progression-free and Overall Survival After Regional Therapy to the Liver for Metastatic Melanoma
    Abbott, Andrea M.
    Doepker, Matthew P.
    Kim, Youngchul
    Perez, Matthew C.
    Gandle, Cassandra
    Thomas, Kerry L.
    Choi, Junsung
    Shridhar, Ravi
    Zager, Jonathan S.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (08): : 747 - 753
  • [43] ANALYSIS OF THE CORRELATION OF TIME TO TREATMENT FAILURE WITH OVERALL SURVIVAL VERSUS CORRELATION OF PROGRESSION-FREE SURVIVAL WITH OVERALL SURVIVAL
    Gibson, G. D.
    Henegan, J. C.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2022, 70 (02) : 548 - 548
  • [44] Association Between Intermediate End Points, Progression-free Survival, and Overall Survival in First-line Advanced or Recurrent Endometrial Cancer
    Garside, Jamie
    Shen, Qin
    Westermayer, Bernd
    van de Ven, Michiel
    Kroep, Sonja
    Chirikov, Viktor
    Juhasz-Boess, Ingolf
    CLINICAL THERAPEUTICS, 2023, 45 (10) : 983 - 990
  • [45] Overall survival with non-proportional hazards in first-line treatment for patients with metastatic colorectal cancer: Systematic review and network meta-analysis
    Keshavarzi, Fatemeh
    Salari, Nader
    Jambarsang, Sara
    Tabatabaei, Seyyed Mohammad
    Shahsavari, Soodeh
    Fournier, Andrew J.
    HELIYON, 2024, 10 (16)
  • [46] Association between progression-free survival and overall survival in women receiving first-line treatment for metastatic breast cancer: evidence from the ESME real-world database
    Courtinard, Coralie
    Gourgou, Sophie
    Jacot, William
    Carton, Matthieu
    Guerin, Olivier
    Vacher, Laure
    Bertaut, Aurelie
    Le Deley, Marie-Cecile
    Perol, David
    Marino, Patricia
    Levy, Christelle
    Uwer, Lionel
    Perrocheau, Genevieve
    Schiappa, Renaud
    Bachelot, Florence
    Parent, Damien
    Breton, Mathias
    Petit, Thierry
    Filleron, Thomas
    Loeb, Agnes
    Pelissier, Simone Mathoulin
    Robain, Mathieu
    Delaloge, Suzette
    Bellera, Carine
    BMC MEDICINE, 2023, 21 (01)
  • [47] COST-EFFECTIVENESS OF VEMURAFENIB AS A FIRST-LINE TREATMENT IN PATIENTS WITH BRAF V600 MUTATION-POSITIVE UNRESECTABLE OR METASTATIC MELANOMA IN SPAIN
    Rubio-Terres, C.
    Orofino, J.
    Armas, J.
    Parra, J.
    Rubio-Rodriguez, D.
    Grau, S.
    VALUE IN HEALTH, 2015, 18 (07) : A453 - A453
  • [48] Positive relationship between subsequent chemotherapy and overall survival in pancreatic cancer: meta-analysis of postprogression survival for first-line chemotherapy
    Kasuga, Akiyoshi
    Hamamoto, Yasuo
    Takeuchi, Ayano
    Kawasaki, Kenta
    Suzuki, Takeshi
    Hirata, Kenro
    Sukawa, Yasutaka
    Takaishi, Hiromasa
    Kanai, Takanori
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (03) : 595 - 602
  • [49] Positive relationship between subsequent chemotherapy and overall survival in pancreatic cancer: Meta-analysis of postprogression survival for first-line chemotherapy
    Kasuga, Akiyoshi
    Hamamoto, Yasuo
    Takeuchi, Ayano
    Kawasaki, Kenta
    Suzuki, Takeshi
    Hirata, Kenro
    Sukawa, Yasutaka
    Takaishi, Hiromasa
    Kanai, Takanori
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 257 - 257
  • [50] Positive relationship between subsequent chemotherapy and overall survival in pancreatic cancer: meta-analysis of postprogression survival for first-line chemotherapy
    Akiyoshi Kasuga
    Yasuo Hamamoto
    Ayano Takeuchi
    Kenta Kawasaki
    Takeshi Suzuki
    Kenro Hirata
    Yasutaka Sukawa
    Hiromasa Takaishi
    Takanori Kanai
    Cancer Chemotherapy and Pharmacology, 2017, 79 : 595 - 602
12345